The Patient-Derived Xenograft (PDX) model has emerged as a cornerstone in preclinical research, offering a promising bridge between laboratory findings and clinical outcomes. By implanting human tumor tissues into immunodeficient mice, PDX models maintain the histological architecture and genetic makeup of the original patient's tumor, thus providing a more accurate representation of human...
English
Arabic
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian